← Back
$STOK All transactions

Stoke Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$174K

Shares

4,355

Price

$40

Filed

Mar 12

Insider

Name

TZIANABOS ARTHUR

Title

Interim Executive Chair

CIK

0001586226

Roles

Director Officer

Transaction Details

Transaction Date

2026-03-10

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

31,339

Footnotes

The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2025. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.095 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | Effective October 6, 2025, this option became fully vested and exercisable.

Filing Info

Accession No.

0001586226-26-000002

Form Type

4

Issuer CIK

0001623526

TZIANABOS ARTHUR's History

Date Ticker Type Value
2026-03-10 STOK M $33K
2026-03-10 STOK $174K
2026-03-10 STOK M $0
2025-10-23 QTTB A $0

Other Insiders at STOK (90d)

Insider Bought Sold Last
LEVIN ARTHUR A $22K 2026-03-13
SMITH IAN F
Chief Executive Officer
2026-02-17
Kaye Edward M. MD 2026-03-15
TZIANABOS ARTHUR
Interim Executive Chair
2026-03-10
Hoitt Jason
Chief Patient Officer
$119K 2026-03-18
Leggett Thomas
Chief Financial Officer
$147K 2026-03-18
Krainer Adrian R. $1.6M 2026-03-10
Ticho Barry
CHIEF MEDICAL OFFICER
$517K 2026-04-01
Kahn Clare 2026-04-03
Allan Jonathan
GENERAL COUNSEL & CORP SEC
$599K 2026-03-20